Dr. Forum Kamdar, MD

Dr. Kamdar practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Kamdar's NPI, 1043548548, was assigned on November 23, 2009. Dr. Kamdar graduated from University of Minnesota Medical School in 2008. Dr. Kamdar holds Minnesota license 53594.

Dr. Kamdar's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Kamdar's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Kamdar is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Kamdar to 6 more group practices and clinics, 5 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kamdar practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kamdar's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kamdar is licensed in Minnesota.

CMS data shows 204 Medicare services from Dr. Kamdar across 5 procedure codes in 2024, for 76 Medicare patients. Medicare paid $20,165 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 76 Medicare patients who saw Dr. Kamdar in 2024. The largest group is under 65, with 34 patients. 75% of them have heart failure, and 75% have high blood pressure. 39% are also on Medicaid. Their average risk score is 3.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kamdar's median patient age at 53, with 45% women.

In 2024, Dr. Kamdar wrote 243 Medicare Part D claims for 38 patients. 81% of them were for generic drugs. CMS names the drug for 144 of them, across 8 drugs with 11 or more claims each, at $36,956 in total drug cost. In 2023, CMS named 178 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Kamdar for performance year 2024, reported as part of a group. Dr. Kamdar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kamdar as offering telehealth.

Dmand AI links 33 papers to Dr. Kamdar, published from 2011 to 2023. 2022 was the busiest year, with 7. The most frequent topics are Heart Failure, Heart-Assist Devices and Cardiomyopathies. Dr. Kamdar has published most often in J Card Fail. Dr. Kamdar's most frequent co-authors are Tamas Alexy, MD, PhD, Daniel Joseph Garry, MD and Ranjit John, MD.

CMS Open Payments shows 71 general payments to Dr. Kamdar from 5 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 56% of the total. Abbott Laboratories paid the most, $7,594.

Dr. Kamdar graduated from University of Minnesota Medical School in 2008.